Exane Derivatives’s Align Technology ALGN Stock Holding History

Exane Derivatives’s Portfolio ALGN Stock Details ALGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	-$436	–	775
2022 Q1	$436	Hold	1	–	–	﹤0.01%	881
2021 Q4	$657	Sell	1 -2,289	-100%	-$1.47M	﹤0.01%	744
2021 Q3	$1.52M	Buy	2,290 +292	+15%	+$198K	0.37%	56
2021 Q2	$1.28M	Buy	+1,998	New	+$1.18M	0.29%	77
2021 Q1	–	Sell	-22	Closed	-$11.8K	–	897
2020 Q4	$11.8K	Hold	22	–	–	﹤0.01%	519
2020 Q3	$7.2K	Hold	22	–	–	﹤0.01%	483
2020 Q2	$6.04K	Hold	22	–	–	﹤0.01%	439
2020 Q1	$3.83K	Hold	22	–	–	﹤0.01%	468
2019 Q4	$6.03K	Hold	22	–	–	﹤0.01%	428
2019 Q3	$3.98K	Sell	22 -328	-94%	-$68.2K	﹤0.01%	460
2019 Q2	$95.8K	Buy	+350	New	+$106K	0.02%	334
2019 Q1	–	Sell	-190	Closed	-$39.8K	–	651
2018 Q4	$39.8K	Buy	+190	New	+$48K	0.01%	377

Other funds holding ALGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Exane Derivatives's ALGN Position: Q2 2022 in Review

Exane Derivatives sold out of Align Technology (ALGN) in Q2 2022, closing a stake of 1 share — an estimated $436 sold.

Exane Derivatives first reported a position in ALGN in Q4 2018 and held it in 12 quarters. The position peaked at $1.52M in Q3 2021. 747 funds tracked by Wall St. Rank hold ALGN as of Q2 2022.

Exane Derivatives reported no remaining Align Technology position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1 Align Technology share in Q2 2022, an estimated $436.
Exane Derivatives first reported a position in Align Technology in Q4 2018 and held it in 12 quarters.
Exane Derivatives's Align Technology position peaked at $1.52M in Q3 2021.
747 funds tracked by Wall St. Rank held Align Technology as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.